• Cipla Medpro Suspends CEO for "Serious" Charges More...

• Myrexis, Inc. Announces Death of Chief Executive Officer Richard B. Brewer, Trailblazing Biotechnology Industry Veteran and Patient Advocate More...

• Forty Year Industry Veteran Randall E. Woods Named CEO at Sophiris Bio More...

• Dr. Harold Schoenhaus Joins the Scientific Advisory Board of Alliqua, Inc. (Formerly known as HepaLife Technologies Inc.) (ALQA) More...

• Fluidigm Corporation Prices $52.2 Million Public Offering of Common Stock More...

• Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, Creates Itonis Pharmaceuticals, a New Division of Itonis, Inc. More...

• TG Therapeutics, Inc., Rhizen Pharmaceuticals Ink Deal Worth Up to $250 Million More...

• Biogen Idec, Inc. (Massachusetts) (BIIB), Regulus Therapeutics, Inc. Cut Deal to Monitor MS More...

• BioTime (BTX) and OncoCyte Corporation Publish Data on the Gene COL10A1 as a Marker and Potential Diagnostic for a Wide Array of Human Cancers More...

• DARA BioSciences, Inc. Announces Soltamox® Distribution Partnership in the Commonwealth of Puerto Rico More...

• Quotient Biodiagnostics Signs 36 Month Agreement With the Premier Healthcare Alliance to Supply Blood Bank Reagents to Its 2,600 Member Hospitals More...

• Bio-Path Holdings, Inc. (BPTH) Reports Second Quarter 2012 Operational and Financial Results More...

• Genmab A/S (GEN.CO) Announces Financial Results for the First Half 2012 and Improves 2012 Financial Guidance More...

• Navidea Biopharmaceuticals (NEOP) Announces 2012 Annual Meeting Results More...

• Probi: Lower Second-Quarter Income but Continued Growth for Full-Year 2012 More...

• Perrigo Company (PRGO) Reports Record Fourth Quarter and Fiscal Year Revenue, Earnings and Cash Flow From Operations More...

• ImmusanT, Inc. Relocates Offices to State-of-the-Art Innovation Facility More...

• Idenix Pharmaceuticals, Inc. (IDIX) Shares Plunge on Hep C Tx Heart Fears More...

• Novartis AG (NVS) Eye Drug Shows Promise in Study More...

• Pfizer Inc. (PFE)'s Experimental Drug Works in Ulcerative Colitis More...

• The New England Journal of Medicine Publishes Results From The New England Journal of Medicine and Medivation, Inc. (MDVN)'s Phase 3 AFFIRM Trial of Enzalutamide More...

• Pluristem Therapeutics (PSTI) Receives Approval From Indian Ministry of Health for Use of PLX Cells in Phase II Trial for Treatment of Buerger's Disease More...

• FDA: Codeine Can be Fatal to Some Children More...

• Pharmalucence, Inc. Announces FDA Approval and Orphan Drug Designation for Use of Sulfur Colloid Injection to Locate Lymph Nodes in Malignant Melanoma Patients More...

• IMPAX Laboratories, Inc. (IPXL) Hopes Parkinson's Drug is a Game Changer More...

• Apexigen Announces the Filing of an IND by its Partner, 3SBio Inc. (SSRX) More...

• Dark Chocolate May Help Lower Blood Pressure, National Institute of Integrative Medicine Study More...

• New Drug Extends Life in Men With Advanced Prostate Cancer Patients, Memorial Sloan-Kettering Cancer Center Study More...

• Babies May Not Have a "Moral Compass" After All, University of Otago Study More...

• Gut Bacteria Linked to Obesity and Metabolic Syndrome Identified, University of Maryland School of Medicine Study More...

• Walnuts May Improve Sperm Health, University of California, Los Angeles (UCLA) Study More...

• New Patents Issued to Diffusion Pharmaceuticals More...